Monthly premiums for California health insurance plans sold under former President Barack Obama's health care overhaul will rise by an average of 12.5 percent next year, officials said Tuesday.
Aug 1, 2017
0
1
A new study by the Harvey L. Neiman Health Policy Institute presents initial validation of a novel payer claims-based system using imaging examination modality and body region for classifying radiologists' subspecialty. The ...
Mar 20, 2017
0
0
Clinical commissioning groups (CCGs) in England have accepted hundreds of payments from drug companies that they have not disclosed to patients and the public, reveals an investigation by The BMJ today.
Jan 3, 2018
0
2
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0
(HealthDay)—Many authors of dermatology clinical practice guidelines receive industry payments, and these payments are often not accurately disclosed, according to a study published online Oct. 18 in JAMA Dermatology.
Oct 19, 2017
0
0
An experiment in Maryland designed to save health care dollars by shifting services away from expensive hospital-based care and toward less costly primary, preventive and outpatient services has yielded disappointing results.
Apr 2, 2018
0
2
UCLA researchers found inflated charges and significant variation in patterns of payments for surgical care by the Centers for Medicare & Medicaid Services (CMS). That charges were inflated compared with payments disproportionately ...
Mar 2, 2016
0
1
Hope is fading for a Capitol Hill drive to permanently fix Medicare's outdated payment formula and spare doctors from automatic cuts in their fees next month. Now the question is whether lawmakers can regroup and come up ...
Mar 21, 2014
0
0
(HealthDay)—Adding computer-aided detection to mammograms finds more early, noninvasive cancers and helps detect invasive cancers at earlier stages, according to a large new study. But the jury's still out as to how worthwhile ...
Apr 16, 2013
0
0
Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle US claims linked to its diabetes drug Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday.
Apr 1, 2015
0
12
